A 68-year-old man with persistent bacteremia accompanying a large iliopsoas abscess, vertebral osteomyelitis, discitis and central venous port infection caused by methicillin-resistant Staphylococcus aureus (MRSA) was admitted to our hospital. During the course of treatment, the emergence of a daptomycin (DAP)-resistant MRSA strain was confirmed; the minimum inhibitory concentration was 1 to 2 μg/mL for vancomycin and more than 1 μg/mL for DAP. Although the bacterial cell wall was not significantly thickened, an increased positive surface charge and single-nucleotide polymorphism within mprF have been confirmed in DAPresistant strains. Still rare, but clinicians need to be cautious of the emergence of DAP-resistant MRSA during treatment.
Introduction
Daptomycin (DAP), a novel cyclic lipopeptide with a unique structure, is active against Gram-positive bacteria, particularly methicillin-resistant Staphylococcus aureus (MRSA) (1) . In the presence of an adequate calcium concentration, the lipophilic tail of DAP inserts itself into the bacterial cell membrane, leading to the effusion of potassium ions and subsequent depolarization of the bacterial membrane. Due to its high bactericidal effect and preferable pharmacokinetics, DAP is widely recommended for the treatment of various infections, such as soft tissue infections, musculoskeletal system infections, bacteremia and endocarditis (2) . However, the emergence of DAP-resistant strains during treatment has recently been noted (3, 4) , although this issue is still not well described in Japan. We experienced such a phenomenon while treating a patient suffering from persistent MRSA bacteremia with vancomycin (VCM) and DAP. The clinical course of the current case and A B nous port. Laboratory testing showed a highly inflammatory state (serum C-reactive protein level, 14.4 mg/dL). Moreover, contrast-enhanced computed tomography (CT) revealed a left iliopsoas abscess (Fig. 1A) , and magnetic resonance imaging demonstrated thoracic discitis. The lesions were independent and had no direct link with each other. There were no pulmonary lesions, and the results of a transthoracic echocardiograph were not indicative of valvular regurgitation or vegetation. Transesophageal echocardiography was not performed. Percutaneous CT-guided drainage of the iliopsoas abscess was conducted on the day of admission, and the intravenous administration of meropenem and VCM (1.5 g/day) was initiated empirically. The serum trough level of VCM was 25.5 μg/mL on day 4, and the antibiotic therapy was converted to DAP (270 mg/day; approximately 6 mg/ kg) alone on day 5, considering the superior tissue permeability of this drug. However, follow-up blood cultures obtained on days 5 and 7 were again positive for MRSA. The results of susceptibility testing for MRSA revealed that the strain was susceptible to both VCM and DAP (Table) , and the central venous port was suspected as a possible bacterial reservoir and subsequently extracted on day 9. Purulent fluid was obtained from the reservoir pocket, and MRSA was also isolated from the site. For the purpose of reducing the bacterial load, drainage of the iliopsoas abscess was again performed percutaneously on day 6, and discectomy was additionally carried out on day 11. Furthermore, due to the patient's refractory course, an indwelling drainage tube was placed in the cavity of the iliopsoas abscess on day 12. Irrigation with normal saline was then performed every day until day 35.
Even with these treatments, however, MRSA was repeatedly isolated from blood cultures. Eventually, a strain with a higher minimum inhibitory concentration (MIC) of DAP was isolated on day 17. The MIC of DAP was elevated from the susceptible category (less than 1 μg/mL) to the resistant category (Table) , while that of VCM was also elevated (1 to 2 μg/mL), although it remained within the susceptible category. The MICs of other antibiotics were as follows: ampicillin, 8 μg/mL; cefazolin, >32 μg/mL gentamycin, 8 μg/mL; levofloxacin, >4 μg/mL; clindamycin, >4 μg/ mL ; minocycline, > 8 μg / mL ; trimethoprimsulfamethoxazole, <0.5 μg/mL; teicoplanin <2 μg/mL; and linezolid, <1 μg/mL.
Linezolid was alternatively administered, and the persistent bacteremia was confirmed to have disappeared on day 30; however, the vertebral osteomyelitis and discitis largely remained (Fig. 1B) . The patient's general condition gradually deteriorated and he finally died on day 135. The clinical course of this case is summarized in Fig. 2 .
Bacterial analysis
We confirmed the identification of the Pre-Abx and PostAbx strains using the phage open-reading frames typing (POT) method. This method has equal utility to that of pulsed-field gel electrophoresis (PFGE) in discriminating S. aureus subtypes and has been applied for surveillance during MRSA outbreaks (5, 6). The POT pattern was determined to be (93-159-111) using the Cica Geneus Staph POT kit (Kanto Chemical, Tokyo, Japan). According to the manufacturer's instructions, it was predicted that the strains contained the SCCmec IIa element and were NY/Japan clones.
We then compared the strain obtained from the initial blood culture (Pre-Abx) with that obtained 17 days after treatment (Post-Abx) in order to determine the mechanism underlying the elevated MIC value for DAP.
First, changes in the bacterial cell wall thickness were examined in the two strains. The samples were fixed in 1% glutaraldehyde for 1 hour at 4 and subsequently embed- ded after fixation in 1% osmium tetroxide for 1 hour at 4 and dehydration. The thickness of the cell wall was measured by an investigator using transmission electron microscopy. In each case, five bacterial cells were randomly selected and five points of the cell walls were measured. The results showed no significant differences in the cell wall thickness between the two strains (Fig. 3) . Second, the changes in the bacterial surface charge were measured. Using a cytochrome c binding assay (7), we compared the relative surface charge of the Pre-Abx with PostAbx strains. The Post-Abx cells bound to a lower amount of positively charged cytochrome c than the Pre-Abx cells. This result shows that the Post-Abx strain exhibited a significantly more relative positive surface charge than the PreAbx strain (p value <0.05) (Fig. 4) .
Third, we investigated single-nucleotide polymorphisms (SNPs) in the multipeptide resistance factor (mprF) gene, which has been reported to be observed in most DAP nonsusceptible MRSA strains (8) . We determined the DNA sequence of the whole region of the mprF in the Post-Abx strain and compared it to that of the Pre-Abx strain. We observed one nucleotide change (C to T) in the Post-Abx strain and found that this mutation occurred at position 1364645 in the S. aureus N315 sequence (GenBang accession no BA000018.3). This point mutation led to the amino acid substitution Thr345 to Ile (T345I) in MprF.
Discussion
In this report, we describe the emergence of a DAPresistant MRSA strain shortly after the initiation of antibiotic therapy. It has been previously shown that the DAPresistant strain occurs as an in vitro phenomenon by stimulating S. aureus with DAP (9). However, the in vivo development of DAP-resistant strains during treatment has also been reported recently (3, (10) (11) (12) (13) .
According to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Clinical and Laboratory Standards Institute (CLSI, M100-S23), strains with an MIC breakpoint of >1 μg/mL are currently defined as resistant or non-susceptible to DAP. In strains with a higher MIC of DAP (>2 μg/mL), the cure rate has been reported to be decreased (14) . Although VCM-resistant strains emerged only after four decades of clinical use, resistance to DAP developed shortly after its debut (15) . Therefore, the emergence of a DAP-resistant strain of MRSA during treatment is of great concern to clinicians.
The mechanisms of DAP resistance have not been fully elucidated, although a few theories involving the cell wall or cell membrane have been proposed. In addition, it is considered that genetic alterations may be related to creeping of the MIC during treatment, as an increase in the MIC first Pre-Abx Post-Abx appears shortly after drug exposure and continues for a prolonged time (12) . First, cell wall thickening is considered to be a possible mechanism (16) . With a thickened cell wall, the permeability of DAP into the bacterial cell membrane may decrease (9, 17) . Although this mechanism has been proposed to play a major role in DAP-resistance, cell wall thickening does not necessarily exist in DAP-resistant MRSA strains (18) . In the current case, transmission electron microscopy did not show any significant changes in the thickness of the bacterial cell wall.
Second, changes in the electrical charge on the bacterial cell surface can be associated with decreased susceptibility. An increased positive surface charge among DAP-resistant strains has previously been reported (19) . In this study, we detected the same phenomenon in our strain; i.e., the PostAbx strain possessed a significantly increased positive cell surface charge compared with the Pre-Abx strain (Fig. 4) .
Third, mutations in genes such as mprF, yycG, rpoB and rpoC are known to be responsible for regulating the surface charge of the bacterial membrane (20) . In the present case, the sequencing analysis of the mprF of Post-Abx strain showed a point mutation leading to the amino acid substitution Thr345 to Ile (T345I), which has been observed in several DAP-non susceptible MRSA strains derived from both patients and laboratories (9, (20) (21) (22) . Since we only investigated the sequence in mprF, there might be other factors, such as SNPs in yyG, rpoB or rpoC, as listed above, in which the Post-Abx strain exhibited a higher positive surface charge than the Pre-Abx strain.
Lastly, another explanation includes the existence of a pre-existing resistant subpopulation (23) . These subpopulations may selectively remain with DAP treatment, and some reports have shown that VCM can select for resistant subpopulations and thus induce creeping of the MIC (24, 25) ; i.e., DAP-resistant strains may emerge during treatment with VCM. In such cases, the duration of VCM therapy prior to the onset of DAP resistance has been reported to range from one to 148 days (26) . In our case, VCM and DAP were administered for a relatively shorter period, five and 12 days, respectively, before the emergence of the resistant strain.
There are some additional mechanisms that may be associated with the emergence of DAP-resistance, such as changes in cellular metabolism or enhanced cell wall turnover (10, 16) .
Hence, whatever the mechanism of resistance, more attention should be paid when VCM or DAP is administered for MRSA infection (12, 26, 27) . In addition to the prior use of these antibiotics, predictors of DAP-resistance include persistent bacteremia and a high bacterial load (27) . Antimicrobial susceptibility testing should also be performed repeatedly during the treatment course, especially in refractory cases. In the present case, the bacterial load was assumed to be high as a result of multiple foci: the iliopsoas abscess, vertebral osteomyelitis, discitis and central venous reservoir infection.
Various strategies have been proposed to prevent the emergence of DAP resistance. The use of a higher dose (8-10 mg/kg) of DAP may decrease the emergence of resistance compared with that of the usual dose (6 mg/kg/ day) (28, 29) , and early surgical intervention may need to be performed aggressively in order to reduce the level of bacterial inoculation (30, 31) . In the present case, although the dose of DAP (approximately 6 mg/kg) might have been small compared with the bacterial load, surgical therapy was performed relatively early in the clinical course. Importantly, the central venous port, a possible bacterial reservoir, should have been extracted earlier.
MIC measurements for DAP can be unreliable if the calcium concentration is not adjusted. In the present case, the MIC value was tested using the VITEK 2, MicroScan WalkAway device and E test. Although the calcium concentration of VITEK 2 is not currently disclosed, the reliability of this method has been demonstrated compared to that of the Clinical and Laboratory Standards Institute (CLSI) broth microdilution reference method (32) . An appropriate calcium concentration in the media for DAP susceptibility testing has been reported to be 50 μg/mL (33) , while that of the MicroScan WalkAway device and E test is set at 47 and 40 μg/ mL, respectively. Therefore, we consider the above results to be trustworthy; i.e., the MRSA strain isolated in our patient had indeed become resistant to DAP during treatment.
In summary, a fatal case of DAP-resistant MRSA infection was herein presented. An increased positive bacterial surface charge and single-nucleotide polymorphism within mprF were detected in the resistant organism. Prior VCM or DAP therapy, high-inoculum infection and the use of a comparatively low dose are assumed to be possible scenarios accounting for the emergence of DAP resistance. Close monitoring for susceptibility of MRSA is needed while treating patients with VCM or DAP.
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